Concepedia

Michael S. Bodnarchuk

MS

20

Publications

859

Citations

15

H-Index

2013

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Southampton

AstraZeneca (United States)

AstraZeneca (Singapore)

Syngenta (United Kingdom)

Michael S. Bodnarchuk is an author at AstraZeneca (United Kingdom) specializing in engineering, biophysics, and computational chemistry.

ORCID

Top concepts

Publications per year

2013–2023

20

Publications

20

Water Sites, Networks, And Free Energies with Grand Canonical Monte Carlo

Gregory A. Ross, Michael S. Bodnarchuk, Jonathan W. Essex · Journal of the American Chemical Society · 2015 · 130 citations

, , +18

Water Network Perturbation in Ligand Binding: Adenosine A<sub>2A</sub>Antagonists as a Case Study

Andrea Bortolato, B.G. Tehan, Michael S. Bodnarchuk et al. · Journal of Chemical Information and Modeling · 2013 · 117 citations

Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines

Sébastien L. Degorce, Michael S. Bodnarchuk, Iain Cumming et al. · Journal of Medicinal Chemistry · 2018 · 86 citations · Full text

Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>

Jason G. Kettle, Sharan K. Bagal, Sue Bickerton et al. · Journal of Medicinal Chemistry · 2020 · 80 citations · Full text

Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors

Kirsten McAulay, Emily Hoyt, Morgan Thomas et al. · Journal of the American Chemical Society · 2020 · 73 citations · Full text

Rows per page

1–5 of 20